# Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

Source: https://onco.cc/trials/nct07424092/  
OnCo record `nct07424092` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of DNX-2401 run by Clinica Universidad de Navarra, Universidad de Navarra, now recruiting.

## Summary

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors is a phase 2 interventional study registered as NCT07424092 by Clinica Universidad de Navarra, Universidad de Navarra, with 39 participants planned, started 2026-05-12. Conditions recorded: High Grade Glioma, Ependymoma, Embryonal Tumor of Brain, Recurrence, Refractory, Pediatric and Young Adult. Interventions recorded: DNX-2401.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07424092
- Phase: 2
- Setting: Intratumoral DNX-2401 Administration for Recurrent and Refractory High Grade Brain Tumors in Pediatric and Young Adult Patients
- Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
- Enrolled: 39

## Sources

- ClinicalTrials.gov NCT07424092: https://clinicaltrials.gov/study/NCT07424092

## Connected records

- cancers: [Brain and spinal cord tumours (all types)](https://onco.cc/cancers/brain-tumours/), [Childhood cancers (all types)](https://onco.cc/cancers/childhood-cancers/), [Ependymoma](https://onco.cc/cancers/ependymoma/)
- drugs: [DNX-2401](https://onco.cc/drugs/dnx-2401/)
- companies: [DNAtrix](https://onco.cc/companies/dnatrix/)

---
JSON: https://onco.cc/api/v1/entities/nct07424092.json